SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-01
👔
Xeris Biopharma Holdings, Inc.
@XERS_InsiderForm 4 Filing: McCulloch Kevin Sells $127K of $XERS
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Xeris Biopharma Holdings, Inc.
Ticker: $XERS
Transaction Value
$127K
Price/Share: $8.49
transaction date
2026-09-01
Shares: 15,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, McCulloch Kevin, holds the title of See Remarks at Xeris Biopharma Holdings, Inc..
On 2026-09-01, the insider transacted 15,000 shares.The shares were transacted at a weighted average price of $8.49 per share, resulting in a total market-relevant value of $127K.
Executive Summary Summary
McCulloch Kevin (See Remarks) sold $127K of $XERS
Post-Transaction Position: 1,639,208 shares
SEC Accession No: 0002031695-26-000011 (CIK: 2031695)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.